UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 165

Sortiert nach

IBS02.02 Making Sense of Treatment with so Many Options: My Algoritm — A North American View

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S90-S91

Lilenbaum, R.

2019

Volltextzugriff (PDF)

Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer

Annals of oncology, 2005-07, Vol.16 (7), p.1069-1075

2005

Volltextzugriff (PDF)

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2003-03, Vol.95 (5), p.341-343

2003

Volltextzugriff (PDF)

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer

Annals of oncology, 2005-01, Vol.16 (1), p.97-101

2005

Volltextzugriff (PDF)

Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S36-S36

2014

Volltextzugriff (PDF)

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : A meta-analysis of response, toxicity, and survival

Cancer, 1998, Vol.82 (1), p.116-126

1998

Volltextzugriff (PDF)

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

Journal of clinical oncology, 1993-07, Vol.11 (7), p.1391-1402

1993

Volltextzugriff (PDF)

Treatment of taste alterations in chemotherapy patients using the “miracle fruit”: Preliminary analysis of a pilot study

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e19523-e19523

2010

Volltextzugriff (PDF)

Making Sense of Treatment with so Many Options: My Algoritm — A North American View: IBS02.02

Journal of thoracic oncology, 2019-10, Vol.14 (10 Suppl), p.S90-S91

Lilenbaum, R

2019

Volltextzugriff (PDF)

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

The New England journal of medicine, 2009-05, Vol.360 (20), p.2055-2065

2009

Volltextzugriff (PDF)

Phase II trial of weekly docetaxel in second‐line therapy for nonsmall cell lung carcinoma

Cancer, 2001-10, Vol.92 (8), p.2158-2163

2001

Volltextzugriff (PDF)

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study

Journal of clinical oncology, 1994-12, Vol.12 (12), p.2743-2750

1994

Volltextzugriff (PDF)

Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2230-2237

1995

Volltextzugriff (PDF)

Interim safety results from the phase 2 ABOUND.PS2 study evaluating nab-paclitaxel (nab-P) + carboplatin (C) followed by nab-P monotherapy in patients (pts) with NSCLC and an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 2

Annals of oncology, 2016-10, Vol.27, p.vi443-vi443

2016

Volltextzugriff (PDF)

Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer

Chest, 2003-01, Vol.123 (1), p.226S-243S

2003

Volltextzugriff (PDF)

OA10.04 Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results from SWOG S1403

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S343-S344

2018

Volltextzugriff (PDF)

Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

Journal of clinical oncology, 2005-01, Vol.23 (1), p.190-196

2005

Volltextzugriff (PDF)

Single-agent versus combination chemotherapy in advanced non-small cell lung cancer : A meta-analysis and the cancer and leukemia group B randomized trial

Seminars in oncology, 1999-10, Vol.26 (5), p.52-54

1999

Volltextzugriff (PDF)

Systemic treatment of Kaposi's sarcoma : current status and future directions

AIDS (London), 1994-02, Vol.8 (2), p.141-151

1994

Volltextzugriff (PDF)

Stage IIIA Category of Non—Small—Cell Lung Cancer: a New Proposal

JNCI : Journal of the National Cancer Institute, 1994-04, Vol.86 (8), p.586-588

1994

Volltextzugriff (PDF)

Trial of poor performance status patients (ToPPS): A randomized phase II trial of pemetrexed versus pemetrexed/bevacizumab versus pemetrexed/carboplatin/bevacizumab in patients with stage IIIb/IV non-small cell lung cancer and ECOG performance status 2

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS287-TPS287

2010

Volltextzugriff (PDF)

Copper deficiency‐induced anemia and neutropenia secondary to intestinal malabsorption

American journal of hematology, 1995-01, Vol.48 (1), p.45-47

1995

Volltextzugriff (PDF)

Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S36-S36

2014

Volltextzugriff (PDF)

Treatment of Taste Alterations in Chemotherapy Patients Using "Miracle Fruit"

Psycho-oncology (Chichester, England), 2012-02, Vol.21, p.58-58

2012

Volltextzugriff (PDF)

The efficacy and cost effectiveness of new antiemetic guidelines

Oncology nursing forum, 1999-10, Vol.26 (9), p.1453

1999

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(153)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(96)
Science & Technology
(96)
Humans
(55)
Female
(44)
Oncology
(39)
Animals
(37)
Veterinary Sciences
(35)
Biological And Medical Sciences
(34)
Male
(31)
Medical Sciences
(28)
Aged
(27)
Lung Neoplasms - Drug Therapy
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(25)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(25)
Middle Aged
(24)
Chemotherapy
(21)
Microbiology
(19)
Cattle
(17)
Pharmacology. Drug Treatments
(16)
Adult
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

IBS02.02 Making Sense of Treatment with so Many Options: My Algoritm — A North American View

Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer

Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC)

Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : A meta-analysis of response, toxicity, and survival

Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer

Treatment of taste alterations in chemotherapy patients using the “miracle fruit”: Preliminary analysis of a pilot study

Making Sense of Treatment with so Many Options: My Algoritm — A North American View: IBS02.02

Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

Phase II trial of weekly docetaxel in second‐line therapy for nonsmall cell lung carcinoma

Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study

Phase I study of paclitaxel and topotecan in patients with advanced tumors: a cancer and leukemia group B study

Interim safety results from the phase 2 ABOUND.PS2 study evaluating nab-paclitaxel (nab-P) + carboplatin (C) followed by nab-P monotherapy in patients (pts) with NSCLC and an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 2

Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer

OA10.04 Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results from SWOG S1403

Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

Single-agent versus combination chemotherapy in advanced non-small cell lung cancer : A meta-analysis and the cancer and leukemia group B randomized trial

Systemic treatment of Kaposi's sarcoma : current status and future directions

Stage IIIA Category of Non—Small—Cell Lung Cancer: a New Proposal

Trial of poor performance status patients (ToPPS): A randomized phase II trial of pemetrexed versus pemetrexed/bevacizumab versus pemetrexed/carboplatin/bevacizumab in patients with stage IIIb/IV non-small cell lung cancer and ECOG performance status 2

Copper deficiency‐induced anemia and neutropenia secondary to intestinal malabsorption

Randomized Phase 2 Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Single-Agent Chemotherapy in Previously Treated KRAS Mutant Advanced Non-Small Cell Lung Cancer (NSCLC): Metastatic Non-Small Cell Lung Cancer

Treatment of Taste Alterations in Chemotherapy Patients Using "Miracle Fruit"

The efficacy and cost effectiveness of new antiemetic guidelines

Suchergebnisse filtern